Academic literature on the topic 'Nitro-4H'

4-Aryl-2-amino-4H-chromenes possessing N,N-dimethylamino group have been reported as potential anticancer drugs. Despite few synthetic methods reported in the literature for their synthesis, there appear to be no reports on the direct use of N,N-dimethyl-3-aminophenol for the synthesis of 4- aryl-2-methylamino-3-nitro-4H-chromenes. One-pot condensation of N,N-dimethyl-3-aminophenol, aromatic aldehydes and (E)-N-methyl-1-(methylthio)-2-nitro-ethenamine was carried out using MW irradiation to get the 4-aryl-2-methylamino-3-nitro-4H-chromenes under catalyst-free conditions. This transformation presumably occurs via o-quinone methide formation, Michael addition-intramolecular O-cyclization-elimination sequence of reactions creating new two C-C bonds and one C-O bond. Various substituted aromatic aldehydes reacted smoothly with N,N-dimethyl-3-aminophenol and (E)-Nmethyl- 1-(methylthio)-2-nitro-ethenamine to give the corresponding 4-aryl-2-methylamino-3-nitro-4Hchromenes in good yields. We have developed a one-pot three component condensation of N,Ndimethyl- 3-aminophenol, aromatic aldehyde and NMSM for the synthesis of N,N-dimethylamino substituted 4-aryl-2-methylamino-3-nitro-4H-chromenes in good yields. The significant features of this reaction include catalyst-free, solvent free, no column chromatographic purification, short reaction time and good yields.

The new 2,9-dimethyl-4H-oxazolo[5’,4’:4,5]pyrano[3,2-f]quinolin-4-one was successfully prepared through the three-component iodine-catalyzed reaction of n-butyl vinyl ether with the new 8-amino-2-methyl-4H-chromeno[3,4-d]oxazol-4-one. The latter was prepared by the reduction of 2-methyl-8-nitro-4H-chromeno[3,4-d]oxazol-4-one with Pd/C in a hydrogen atmosphere. The above nitro compound was synthesized by the condensation of N-(4-hydroxy-6-nitro-2-oxo-2H-chromen-3-yl)acetamide with P2O5 under microwave irradiation. The above acetamide derivative was prepared during the nitration of 2-methyl-4H-chromeno[3,4-d]oxazol-4-one with H2SO4 and KNO3. The structure of the newly synthesized compounds was confirmed by FT-IR, LC-MS, 1H-NMR, and 13C-NMR analyses. Preliminary biological tests show significant anti-lipid peroxidation activity for the title compound and the other synthesized new intermediates, as well as interesting soybean lipoxygenase inhibition for acetamide 2 (IC50 55 μM) and nitro-compound 3 (IC50 27 μM).

The present work reports synthesis and characterization of different benzoxazinone derivatives. 2-methyl-7-nitro-4H-3,1-benzoxazin-4-one was prepared by refluxing 4- nitroanthranilic acid with acid anhydride. Derivatives of 2-methyl-7-nitro-4H-3,1-benzoxazin-4-one were synthesized by condensation of it with different anilines. Elemental analysis and NMR spectral studies were used to confirm the formation of compounds.

The three pyran structures 6-methylamino-5-nitro-2,4-diphenyl-4H-pyran-3-carbonitrile, C19H15N3O3, (I), 4-(3-fluorophenyl)-6-methylamino-5-nitro-2-phenyl-4H-pyran-3-carbonitrile, C19H14FN3O3, (II), and 4-(4-chlorophenyl)-6-methylamino-5-nitro-2-phenyl-4H-pyran-3-carbonitrile, C19H14ClN3O3, (III), differ in the nature of the aryl group at the 4-position. The heterocyclic ring in all three structures adopts a flattened boat conformation. The dihedral angle between the pseudo-axial phenyl substituent and the flat part of the pyran ring is 89.97 (1)° in (I), 80.11 (1)° in (II) and 87.77 (1)° in (III). In all three crystal structures, a strong intramolecular N—H...O hydrogen bond links the flat conjugated H—N—C=C—N—O fragment into a six-membered ring. In (II), molecules are linked into dimeric aggregates by N—H... O(nitro) hydrogen bonds, generating anR22(12) graph-set motif. In (III), intermolecular N—H...N and C—H...N hydrogen bonds link the molecules into a linear chain pattern generatingC(8) andC(9) graph-set motifs, respectively.

A series of new 6-substituted-1,3-dimethyl-1H-pyrazolo[3,4-b]pyrazin-5(4H)-ones (13a - e) and 1,3-dimethyl-5a,6a,7,8-tetrahydro-1H-pyrazolo[4,3-e]pyrrolo[1,2-a]pyrazin-5(4H)-one (15) have been synthesized. The synthetic strategy involves direct interaction of D,L-α-amino acids with 5- chloro-1,3-dimethyl-4-nitro-1H-pyrazole (10) to produce the respective N-(1,3-dimethyl-4-nitro-1Hpyrazol- 5-yl) D,L-α-amino acids 11a - e and 14. The latter compounds underwent reductive lactamization to deliver the corresponding target heterocyclic systems 13a - e and 15

Objective: The objective of this work was to synthesize and evaluate antimicrobial properties of 1-(4-methyl-6-nitro-2H-benzo[b][1,4]thiazine- 3(4H)-ylidene)hydrazine-1,1-dioxide derivatives.Methods: These new compounds were synthesized by methylation in 4-N and reacted with hydrazine derivatives and oxidized at the sulfur atom by 30% hydrogen peroxide to obtain sulfones. All the synthesized compounds were evaluated for antimicrobial activity using the disc diffusion method.Results: The Fourier transform infrared, 1H nuclear magnetic resonance (NMR), 13CNMR, and mass studies confirm the synthesis of some new 1-(4-methyl- 6-nitro-2H-benzo[b][1,4]thiazine-3(4H)-ylidene)hydrazine-1,1-dioxide derivatives. Compound 6f showed the potent antimicrobial activity.Conclusion: Result obtained in this research work clearly indicated that the compound 6f having methyl at 2 position and nitro groups at 2′ and 4′ position showed the most potent antimicrobial activity.

Nitroaromatic compounds are very used in the pharmaceutical industry for their known biological properties. One of the probable mechanisms of action of this class of compounds may be involved in redox reactions. The identification of nitro and its products, for a technique simple, sensitive and low cost technique such as electrochemical techniques, is fundamental, because through them it is possible to analyze the solubilization process of these compounds in association with some encapsulating agents. A feature of nitro compound studied, 2 - [(4-nitrophenyl) amino]-4,5,6,7-tetrahydro-4H-benzo [β] thiophene-3-carbonitrile, (6CN10) is its low solubility in water, which justifies its combination with substances such as cyclodextrin and dendrimers, such as PAMAM. The formation of an inclusion complex between 6CN10 and β-cyclodextrin and 6CN10 and PAMAM 3rd generation was evaluated in this work through electrochemical and spectroscopic techniques. The electrochemical system was composed of three electrodes, Ag/AgCl/Cl- saturated (reference), platinum (auxiliary), glassy carbon with and without modification with carbon nanotubes (NTC) or gold (Au) (working) in a buffered medium pH 7.03 with and without a cosolvent and a Na2SO4 solution of 0.2 mol L-1. Also was performed spectroscopic studies by UVVis in aqueous-ethanolic medium in different concentrations of β-Cyclodextrin, as well as the characterization of the complex 6CN10: PAMAM in methanolic solution. The studies demonstrated that the 6CN10 has standard reduction mechanism of nitroaromatic in potential within the expected range for compounds with biological activity its mechanism of action may be associated with the redox process The first analysis showed the interaction of 6CN10 as β-CD and the influence of time in this process. By forming a self-assembled monolayer (SAM) of β-CD-SH on the Au electrode it was possible to determine the equilibrium constant between the complex 6CN10:β-CD with value 3,3x105 M-1. Already by spectrophotometric methods, the constant was 7,86x104 M-1. Regarding the PAMAM the first results verified the influence of time on complex formation between 6CN10:PAMAM, reaching the optimum time of 30 minutes. Then With the increasing variations in the concentration of 6CN10 it was possible to determine the equilibrium constant (KF = 5,61x105 M-1) between the complex 6CN10:PAMAM, in NTC sensor. It is observed that the obtained value is relatively higher in comparison with the electrochemical constant for the complex 6CN10:β-CD. This favoring behavior 6CN10:PAMAM complex can also be observed by the values of LD and LQ obtained, which were, respectively, 1,49x10-6 and 4,96x10-6 mol L-1 to the complex with PAMAM and 1,83x10-6 and 6,1x10-6 mol L-1 to β-CD. When the SAM of PAMAM-MUA was used the constant obtained was of 2,16x105 M-1. In characterizing the 6CN10:PAMAM complex per UV-Vis, the results show that a higher amount than the number of PAMAM ramifications (32 ramifications) and of the 6CN10 interacted, suggesting that the nitro interacted of different forms with PAMAM. Both encapsulating agents demonstrated efficiency for complex formation with the compound under study, but PAMAM presented subtle advantage. However both could be used for the development of different pharmaceutical formulations containing the nitro compound.
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Os nitrocompostos aromáticos são muito aplicados na indústria farmacêutica por suas conhecidas propriedades biológicas. Um dos prováveis mecanismos de ação dessa classe de compostos pode estar envolvido em reações de oxirredução. A identificação do nitro e de seus produtos, por uma técnica simples, sensível e de baixo custo como as técnicas eletroquímicas, é fundamental, pois através delas é possível analisar o processo de solubilização desses compostos em associação com alguns agentes encapsulantes. Uma característica do nitrocomposto estudado, 2-[(4-nitrofenil)-amino]-4,5,6,7-tetraidro-4H-benzo[b]tiofeno-3-carbonitrila, (6CN10) é sua baixa solubilidade em água, o que justifica sua associação com substâncias como ciclodextrina e dendrímeros, como o PAMAM. A formação de um complexo de inclusão entre o 6CN10 e a β-Ciclodextrina e 6CN10 e PAMAM 3ª geração foi avaliado nesse trabalho através das técnicas eletroquímicas e espectroscópicas. O sistema eletroquímico utilizado foi composto por 3 eletrodos, Ag/AgCl/Cl- saturado (referência), platina (auxiliar), carbono vítreo com e sem modificação com nanotubos de carbono (NTC) ou ouro (Au) (trabalho), em meio tamponado pH 7,03 com e sem um cosolvente, e em uma solução de Na2SO4 a 0,2 mol L-1. Também foram realizados estudos espectroscópicos por UV-Vis em meio aquoso-etanólico em diferentes concentrações de β-Ciclodextrina, bem como a caracterização do complexo 6CN10:PAMAM em solução metanólica. Os estudos demonstraram que o 6CN10 possui mecanismo de redução padrão de nitroaromáticos com potencial dentro da faixa esperada para compostos com atividade biológica, podendo seu mecanismo de ação estar associado ao processo redox. As primeiras analises demonstram a interação do 6CN10 como β-CD e a influência do tempo nesse processo. Através da formação de uma monocamada auto-organizada (SAM) de β-CD-SH no eletrodo de Au, foi possível determinar a constante de equilíbrio entre o complexo 6CN10:β-CD com valor de 3,3x105 M-1. Já por métodos espectrofotométricos, a constante foi de 7,86x104 M-1. Em relação ao PAMAM os primeiros resultados verificaram a influência do tempo na formação do complexo entre 6CN10:PAMAM, chegando ao tempo otimizado de 30 min. Em seguida, com as variações crescentes na concentração de 6CN10 foi possível determinar a constante de equilíbrio (Kf=5,61x105 M-1) entre o complexo 6CN10:PAMAM em sensor de NTC. Observou-se que o valor obtido é relativamente maior em comparação com a constante eletroquímica para o complexo 6CN10:β-CD. Tal comportamento de favorecimento do complexo 6CN10:PAMAM também pode ser observado pelo valores de LD e LQ obtidos, que foram, respectivamente, 1,49x10-6 e 4,96x10-6 mol L-1 para o complexo com PAMAM e de 1,83x10-6 e 6,1x10-6 mol L-1 para β-CD. Quando a SAM de PAMAM-MUA foi utilizada, a constante obtida foi de 2,16x105 M-1. Ao caracterizar o complexo 6CN10:PAMAM por UV-Vis, os resultados demostraram que uma quantidade maior que o nº de ramificações do PAMAM (32 ramificações) e do 6CN10 interagiram, propondo que o nitro interage por diferentes formas com o PAMAM. Ambos os agentes encapsulantes demonstraram eficiência para formação do complexo com o composto em estudo, porém o PAMAM apresentou uma sutil vantagem. Entretanto, ambos poderiam ser utilizados para o desenvolvimento de diferentes formulações farmacêuticas contendo o nitrocomposto.